Please check your internet connection and try again.
## Overview
Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a combination medication that typically includes an opioid antitussive and potentially other ingredients such as expectorants or antihistamines. The specific formulation and its constituents will dictate its primary use.
## Primary Indications
* Symptomatic relief of cough.
## Adult Dosing
Dosing varies significantly based on the specific formulation. For opioid-containing formulations, typical adult dosing is:
* **Opioid Antitussive (e.g., codeine):** 10-20 mg every 4-6 hours as needed. Maximum dose is typically 120 mg per 24 hours.
* **Other components (e.g., guaifenesin, antihistamines):** Dosing is formulation-dependent and should follow product labeling.
**Note:** Specific dosing regimens may vary based on local protocols and the exact composition of the Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd product.**
## Pediatric Dosing
**Generally not recommended for children under 12 years of age, especially for formulations containing codeine, due to increased risk of respiratory depression and death.** For children aged 12-18 years, dosing should be based on body weight and follow product labeling strictly. Use caution and consider lower doses.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary depending on the specific components and degree of impairment.
* **Renal Impairment:** Use with caution; dose reduction may be necessary depending on the specific components and degree of impairment.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Severe respiratory depression.
* Acute or severe bronchial asthma.
* Known rapid metabolizers of codeine via CYP2D6.
* Children recovering from tonsillectomy or adenoidectomy.
## Adverse Effects
Common adverse effects may include:
* Drowsiness, dizziness
* Nausea, vomiting
* Constipation
* Dry mouth
* Respiratory depression (serious and potentially fatal)
* Sedation
* Confusion
## Key Drug Interactions
* **CNS Depressants (e.g., benzodiazepines, alcohol, other opioids):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **CYP2D6 Inhibitors:** May increase codeine plasma concentrations, leading to increased risk of toxicity.
* **MAO Inhibitors:** Potentially life-threatening interactions. Avoid use.
## Monitoring
* **Respiratory rate and depth:** Monitor closely for signs of respiratory depression.
* **Level of consciousness and sedation:** Assess for excessive drowsiness or confusion.
* **Bowel function:** Monitor for constipation and implement preventative measures.
* **Effectiveness of cough suppression.**
## Clinical Pearls
* Codeine is a prodrug metabolized to morphine by CYP2D6. Genetic variations in CYP2D6 can lead to significant differences in drug response.
* Due to the risk of respiratory depression, caution is advised, especially in elderly patients, those with underlying pulmonary disease, and when used concurrently with other CNS depressants.
* Consider non-opioid alternatives for cough management when appropriate.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing and indications may vary based on specific product formulations and local protocols.
